Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 3
1981 1
1982 1
1983 3
1984 1
1985 6
1986 3
1987 3
1988 2
1989 2
1990 1
1991 7
1992 2
1993 4
1994 6
1995 2
1996 3
1997 5
1998 2
1999 3
2000 3
2001 6
2002 5
2003 8
2004 4
2005 15
2006 19
2007 14
2008 25
2009 19
2010 25
2011 39
2012 38
2013 40
2014 36
2015 44
2016 42
2017 56
2018 50
2019 62
2020 78
2021 63
2022 77
2023 80
2024 91
2025 91
2026 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

998 results

Results by year

Filters applied: . Clear all
Page 1
Treating Chronic Pain with Buprenorphine-The Practical Guide.
Case AA, Kullgren J, Anwar S, Pedraza S, Davis MP. Case AA, et al. Curr Treat Options Oncol. 2021 Nov 18;22(12):116. doi: 10.1007/s11864-021-00910-8. Curr Treat Options Oncol. 2021. PMID: 34791564 Review.
It has been recommended to consider buprenorphine first-line opioid for chronic pain, especially in the elderly as it may be associated with less cognitive impairment, falls, sexual dysfunction, and sarcopenia when compared with schedule II opioids. ...When u …
It has been recommended to consider buprenorphine first-line opioid for chronic pain, especially in the elderly as it m …
Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, Adler J, Mallick-Searle T. Webster L, et al. Pain Med. 2020 Apr 1;21(4):714-723. doi: 10.1093/pm/pnz356. Pain Med. 2020. PMID: 31917418 Free PMC article. Review.
OBJECTIVE: An expert panel convened to reach a consensus on common misconceptions surrounding buprenorphine, a Schedule III partial -opioid receptor agonist indicated for chronic pain. The panel also provided clinical recommendations on the appropriate use o …
OBJECTIVE: An expert panel convened to reach a consensus on common misconceptions surrounding buprenorphine, a Schedule III partial …
Buprenorphine for Chronic Pain Management: a Narrative Review.
Vu PD, Bansal V, Chitneni A, Robinson CL, Viswanath O, Urits I, Kaye AD, Nguyen A, Govindaraj R, Chen GH, Hasoon J. Vu PD, et al. Curr Pain Headache Rep. 2023 Dec;27(12):811-820. doi: 10.1007/s11916-023-01185-4. Epub 2023 Oct 28. Curr Pain Headache Rep. 2023. PMID: 37897592 Review.
This review provides physicians and practitioners with updated information regarding the distinct characteristics and intricacies of prescribing buprenorphine. RECENT FINDINGS: Buprenorphine is approved by the US Food and Drug Administration (FDA) for acute pain …
This review provides physicians and practitioners with updated information regarding the distinct characteristics and intricacies of prescri …
Buprenorphine in the Treatment of Chronic Pain.
Rudolf GD. Rudolf GD. Phys Med Rehabil Clin N Am. 2020 May;31(2):195-204. doi: 10.1016/j.pmr.2020.02.001. Epub 2020 Mar 13. Phys Med Rehabil Clin N Am. 2020. PMID: 32279723 Review.
Buprenorphine is an opioid that is available for treatment of both chronic pain and opioid use disorder. ...This article reviews the pharmacology and clinical effectiveness of buprenorphine in the context of chronic pain treatment....
Buprenorphine is an opioid that is available for treatment of both chronic pain and opioid use disorder. ...This articl …
The utilization of buprenorphine in chronic pain.
Urits I, Pham C, Swanson D, Berardino K, Bandi P, Amgalan A, Kaye RJ, Jung JW, Kaye AD, Paladini A, Varrassi G, Kaye AM, Manchikanti L, Viswanath O. Urits I, et al. Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):355-368. doi: 10.1016/j.bpa.2020.06.005. Epub 2020 Jul 3. Best Pract Res Clin Anaesthesiol. 2020. PMID: 33004153 Review.
Reclassification of chronic pain as a disease may be helpful because patients with chronic pain require significant treatment and rehabilitation with a clear diagnosis. ...With unique pharmacological properties, buprenorphine is a safe and effec …
Reclassification of chronic pain as a disease may be helpful because patients with chronic pain require signific …
Buprenorphine buccal film for chronic pain management.
Hale M, Gimbel J, Rauck R. Hale M, et al. Pain Manag. 2020 Jul;10(4):213-223. doi: 10.2217/pmt-2020-0013. Epub 2020 May 12. Pain Manag. 2020. PMID: 32394800 Free article. Review.
This review article focuses on the buccal film formulation, which is preferable to other buprenorphine formulations on the basis of bioavailability, safety and efficacy. The clinical studies reviewed here confirm that buprenorphine buccal film offers effective and c …
This review article focuses on the buccal film formulation, which is preferable to other buprenorphine formulations on the basis of b …
Buprenorphine for Chronic Pain: a Systemic Review.
Fishman MA, Kim PS. Fishman MA, et al. Curr Pain Headache Rep. 2018 Oct 5;22(12):83. doi: 10.1007/s11916-018-0732-2. Curr Pain Headache Rep. 2018. PMID: 30291571
PURPOSE OF REVIEW: The purpose of this review is to evaluate and explain our current understanding of the clinical use of buprenorphine in the treatment of chronic pain. RECENT FINDINGS: There has been few high-quality, unbiased studies performed on the use o …
PURPOSE OF REVIEW: The purpose of this review is to evaluate and explain our current understanding of the clinical use of buprenorphine …
Is Buprenorphine Effective for Chronic Pain? A Systematic Review and Meta-analysis.
Lazaridou A, Paschali M, Edwards RR, Gilligan C. Lazaridou A, et al. Pain Med. 2020 Dec 25;21(12):3691-3699. doi: 10.1093/pm/pnaa089. Pain Med. 2020. PMID: 32330264
METHODS: Two separate searches were conducted to identify buprenorphine trials that included chronic pain patients either with or without OUD. Five studies used validated pain report measures and included a chronic pain population with OU …
METHODS: Two separate searches were conducted to identify buprenorphine trials that included chronic pain patients eith …
Buprenorphine for Pain: A Narrative Review and Practical Applications.
Spinella S, McCarthy R. Spinella S, et al. Am J Med. 2024 May;137(5):406-413. doi: 10.1016/j.amjmed.2024.01.022. Epub 2024 Feb 9. Am J Med. 2024. PMID: 38340973 Review.
Some formulations are approved for chronic pain and others for opioid use disorder. Buprenorphine is an option for patients who use chronic daily opioids for pain. This review summarizes the literature on buprenorphine's efficacy a …
Some formulations are approved for chronic pain and others for opioid use disorder. Buprenorphine is an option for pati …
Pain management in patients with chronic kidney disease and end-stage kidney disease.
Roy PJ, Weltman M, Dember LM, Liebschutz J, Jhamb M; HOPE Consortium. Roy PJ, et al. Curr Opin Nephrol Hypertens. 2020 Nov;29(6):671-680. doi: 10.1097/MNH.0000000000000646. Curr Opin Nephrol Hypertens. 2020. PMID: 32941189 Free PMC article.
PURPOSE OF REVIEW: This review evaluates current recommendations for pain management in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) with a specific focus on evidence for opioid analgesia, including the partial agonist, buprenorphine. ...S …
PURPOSE OF REVIEW: This review evaluates current recommendations for pain management in chronic kidney disease (CKD) and end-s …
998 results